# HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903

> **NCT04975698** · PHASE2 · COMPLETED · sponsor: **Catherine Bollard** · enrollment: 12 (actual)

## Conditions studied

- HIV Associated Lymphoma

## Interventions

- **BIOLOGICAL:** HST-NEETs
- **BIOLOGICAL:** Bone Marrow Transplant

## Key facts

- **NCT ID:** NCT04975698
- **Lead sponsor:** Catherine Bollard
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-25
- **Primary completion:** 2025-11-24
- **Final completion:** 2026-01-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-03-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04975698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04975698, "HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04975698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*